Massively parallel signature sequencing (MPSS) as a tool for in-depth quantitative gene expression profiling in all organisms

  • Jeannette Reinartz
    Group leader Production, Lynx Therapeutics, GmbH, Germany
  • Eddy Bruyns
    Group leader Functional Genomics, Lynx Therapeutics, GmbH Germany
  • Jing-Zhong Lin
    Senior Scientist, Lynx Therapeutics, Inc., Hayward, California, USA.
  • Tim Burcham
    Vice President, IT and Bioinformatics, Lynx Therapeutics, Inc., Hayward, California, USA.
  • Sydney Brenner
    Scientific Advisor for Lynx and Progessor, Salk Institute, La Jolla, California, USA.
  • Ben Bowen
    Vice President, Discovery Research, Lynx Therapeutics, Inc., Hayward, California, USA.
  • Michael Kramer
    Managing Director, Lynx Therapeutics GmbH, Germany.
  • Rick Woychik
    Chief Scientific Officer, Lynx Therapeutics, Inc., Hayward, California, USA.

Journal

Citations (2)*help

See more

Details 詳細情報について

Report a problem

Back to top